Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GROUPE L.M.D. : revenue, balance sheet and financial ratios

GROUPE L.M.D. is a French company founded 24 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in AVIGNON (84000), this company of category PME shows in 2023 a revenue of 6.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GROUPE L.M.D. (SIREN 438790610)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C 6 470 136 € N/C N/C N/C N/C N/C N/C
Net income -36 023 € 232 405 € 321 616 € 422 062 € 438 962 € 61 582 € 145 584 € 86 593 € 201 149 €
EBITDA N/C N/C 408 380 € N/C N/C N/C N/C -49 508 € -24 071 €
Net margin N/C N/C 5.0% N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, GROUPE L.M.D. records a net loss of 36 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-36 023 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 29%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

28.803%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.904%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

41.4%

Solvency indicators evolution
GROUPE L.M.D.

Sector positioning

Debt ratio
28.8 2025
2023
2024
2025
Q1: 0.0
Med: 3.67
Q3: 28.55
Average

In 2025, the debt ratio of GROUPE L.M.D. (28.80) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.9% 2025
2023
2024
2025
Q1: 26.28%
Med: 43.48%
Q3: 62.04%
Average

In 2025, the financial autonomy of GROUPE L.M.D. (37.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
2.75 years 2023
2023
Q1: 0.0 years
Med: 0.0 years
Q3: 1.46 years
Average

In 2023, the repayment capacity of GROUPE L.M.D. (2.75) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 179.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

179.399

Liquidity indicators evolution
GROUPE L.M.D.

Sector positioning

Liquidity ratio
179.4 2025
2023
2024
2025
Q1: 147.44
Med: 215.05
Q3: 310.05
Average -14 pts over 3 years

In 2025, the liquidity ratio of GROUPE L.M.D. (179.40) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
3.61x 2023
2023
Q1: 0.0x
Med: 0.29x
Q3: 6.06x
Good

In 2023, the interest coverage of GROUPE L.M.D. (3.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
GROUPE L.M.D.

Positioning of GROUPE L.M.D. in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare GROUPE L.M.D. with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about GROUPE L.M.D.

What is the revenue of GROUPE L.M.D. ?

The revenue of GROUPE L.M.D. in 2023 is 6.5 M€.

Is GROUPE L.M.D. profitable?

GROUPE L.M.D. recorded a net loss in 2025.

Where is the headquarters of GROUPE L.M.D. ?

The headquarters of GROUPE L.M.D. is located in AVIGNON (84000), in the department Vaucluse.

Where to find the tax return of GROUPE L.M.D. ?

The tax return of GROUPE L.M.D. is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GROUPE L.M.D. operate?

GROUPE L.M.D. operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.